A detailed history of Homestead Advisers Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Homestead Advisers Corp holds 654,504 shares of MRK stock, worth $74.4 Million. This represents 2.01% of its overall portfolio holdings.

Number of Shares
654,504
Previous 665,704 1.68%
Holding current value
$74.4 Million
Previous $87.8 Million 7.76%
% of portfolio
2.01%
Previous 2.07%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$123.8 - $132.96 $1.39 Million - $1.49 Million
-11,200 Reduced 1.68%
654,504 $81 Million
Q1 2024

May 10, 2024

SELL
$113.24 - $131.95 $113,240 - $131,950
-1,000 Reduced 0.15%
665,704 $87.8 Million
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $110,198 - $119,922
1,100 Added 0.17%
666,704 $72.7 Million
Q3 2023

Nov 09, 2023

BUY
$102.95 - $114.33 $1.03 Million - $1.14 Million
10,000 Added 1.53%
665,604 $68.5 Million
Q2 2023

Jul 25, 2023

BUY
$108.61 - $118.38 $347,552 - $378,816
3,200 Added 0.49%
655,604 $75.7 Million
Q1 2023

Apr 27, 2023

SELL
$102.94 - $114.86 $1.41 Million - $1.57 Million
-13,700 Reduced 2.06%
652,404 $69.4 Million
Q4 2022

Feb 03, 2023

SELL
$87.44 - $112.11 $218,600 - $280,275
-2,500 Reduced 0.37%
666,104 $73.9 Million
Q3 2022

Nov 07, 2022

SELL
$84.53 - $94.96 $126,795 - $142,440
-1,500 Reduced 0.22%
668,604 $57.6 Million
Q1 2022

May 12, 2022

SELL
$73.51 - $82.4 $749,802 - $840,480
-10,200 Reduced 1.5%
670,104 $55 Million
Q4 2021

Feb 07, 2022

SELL
$72.28 - $90.54 $354,172 - $443,646
-4,900 Reduced 0.72%
680,304 $52.1 Million
Q3 2021

Nov 05, 2021

BUY
$71.68 - $78.83 $193,536 - $212,841
2,700 Added 0.4%
685,204 $51.5 Million
Q2 2021

Aug 02, 2021

SELL
$70.31 - $77.77 $5.29 Million - $5.86 Million
-75,300 Reduced 9.94%
682,504 $53.1 Million
Q1 2021

May 07, 2021

SELL
$68.86 - $81.11 $12.6 Million - $14.8 Million
-182,400 Reduced 19.4%
757,804 $58.4 Million
Q4 2020

Feb 10, 2021

SELL
$71.77 - $79.65 $1.6 Million - $1.78 Million
-22,300 Reduced 2.32%
940,204 $76.9 Million
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $24.4 Million - $27.6 Million
-333,100 Reduced 25.71%
962,504 $79.8 Million
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $49,294 - $56,091
700 Added 0.05%
1,295,604 $100 Million
Q1 2020

May 14, 2020

SELL
$63.36 - $87.82 $3.06 Million - $4.24 Million
-48,240 Reduced 3.59%
1,294,904 $99.6 Million
Q4 2019

Feb 13, 2020

SELL
$77.58 - $87.54 $1.06 Million - $1.2 Million
-13,699 Reduced 1.01%
1,343,144 $122 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $3.6 Million - $3.93 Million
-47,378 Reduced 3.37%
1,356,843 $114 Million
Q2 2019

Aug 12, 2019

SELL
$69.84 - $81.59 $27.7 Million - $32.4 Million
-397,279 Reduced 22.05%
1,404,221 $118 Million
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $4.87 Million - $5.56 Million
-70,000 Reduced 3.74%
1,801,500 $150 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $110 Million - $118 Million
1,871,500
1,871,500 $120 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Homestead Advisers Corp Portfolio

Follow Homestead Advisers Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Homestead Advisers Corp, based on Form 13F filings with the SEC.

News

Stay updated on Homestead Advisers Corp with notifications on news.